TriAltus Bioscience was founded with a singular vision: to revolutionize the production and supply of ultra-pure enzymes for the life sciences industry. Our journey began when our founders recognized the limitations of traditional enzyme purification methods, particularly for cutting-edge applications like CRISPR gene editing and enzymatic DNA synthesis.

Our Story

Born from the innovative research at the University of Alabama at Birmingham, TriAltus Bioscience emerged as a spinoff company dedicated to commercializing the groundbreaking CLīM™ (CL7/Im7) purification technology. This proprietary system, developed by Dr. Dmitry Vassylyev and his team, has redefined the standards for enzyme purity and activity in the industry.

Our Mission

At TriAltus, we're committed to empowering biotech and life science companies by providing ultra-pure, high-performance enzymes at unbeatable value. We aim to be more than just a supplier; we strive to be a strategic partner in your success, enabling you to focus on innovation while we handle the complexities of enzyme production.

What Sets Us Apart

1. Proprietary CLīM™ Technology: Our unique purification method consistently outperforms traditional approaches, delivering enzymes with exceptional purity, superior activity, and unmatched consistency.
2. Expertise in Genomic Enzymes: We specialize in CRISPR nucleases and other enzymes crucial for advanced genomic applications, staying at the forefront of biotechnological advancements.
3. Flexible Service Model: Whether you need OEM manufacturing, CDMO services, or catalog products, we tailor our offerings to meet your specific requirements.
4. Quality and Compliance: As an ISO13485:2016-compliant company, we adhere to rigorous quality standards, ensuring our products meet the exacting needs of the life sciences industry.
5. Customer-Centric Approach: We work closely with our partners, from small biotechs to leading pharmaceutical companies, to understand and anticipate their unique needs.

Our Impact

TriAltus has quickly become a trusted partner for numerous leading organizations in the life sciences sector. Our CLīM™ Affinity Tag System is supporting the groundbreaking work of renowned institutions such as Amgen, Merck, Dana-Farber Cancer Institute, Mayo Clinic, and Harvard Medical School, among others.

Join Our Journey

Whether you're developing the next breakthrough in gene therapy, advancing CRISPR technology, or pushing the boundaries of enzymatic DNA synthesis, TriAltus Bioscience is here to support your success. Let's revolutionize the world of genomic enzymes together.